Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

ACCURAY INC (ARAY)

$0.26 -2.26% NASDAQ: ARAY · 15-min delayed
  • MADISON, Wisconsin
  • Public · NASDAQ: ARAY
  • 990 employees
$40.7MMarket cap
$458.5MRevenue · FY2025
-$1.6MNet income
990Employees
ARAYNASDAQ
2007IPO

About ACCURAY INC

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$458.5M
Net income
-$1.6M
Total assets
$470.2M
Market cap
$40.7M
Gross margin
32.1%
Operating margin
1.7%
Net margin
-0.3%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$458.5M
Cost of revenue
$311.5M
Gross profit
$147.0M
Operating expenses
$139.1M
Operating income
$7.8M
Income tax
$2.7M
Net income
-$1.6M
EPS (basic)
$-0.02
EPS (diluted)
$-0.02

Balance sheet

Total assets
$470.2M
Current assets
$317.5M
Total liabilities
$389.1M
Current liabilities
$192.6M
Shareholders’ equity
$81.2M

Cash flow

Operating cash flow
$2.9M
Investing cash flow
-$8.5M
Financing cash flow
-$4.3M
Net cash flow
-$8.3M

Statements via Polygon.io (SEC filings)

NASDAQ: ARAY
$0.26 -2.26%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.24 $1.85

52-week range

Market cap
$40.7M
EPS (diluted)
$-0.02
Shares outstanding
156.4M
Open
Day range
Prev close
Volume
IPO date
Feb 8, 2007

Accuray Inc (ARAY) Stock Price

  • Reported a net loss of $1.6M in FY2025.
  • Revenue grew 16% from FY2021 to FY2025.
  • Gross margin of 32.1%, net margin -0.3%.
  • Trading 86% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review ACCURAY INC.

Write a review
Newsroom

News about ACCURAY INC

News & sentiment via Polygon.io

FAQ

Accuray Inc: frequently asked questions

Is Accuray Inc an American company?

Accuray Inc is a US-based company headquartered in Madison, Wisconsin, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Accuray Inc headquartered?

Accuray Inc is headquartered in Madison, Wisconsin, United States.

Is Accuray Inc publicly traded?

Yes — Accuray Inc is a publicly traded company. Its stock trades under the ticker symbol ARAY on the NASDAQ.

What does Accuray Inc do?

Accuray Inc is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →